Avodart & Proscar for Treating Prostate...
(Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - March 7, 2016 Category: Cancer & Oncology Tags: health Source Type: news
Strides Shasun gets USFDA nod to market Dutasteride capsules
The company has received approval from the US Food and Drug Administration (USFDA) to market Dutasteride capsules in the strength of 0.5 mg, Strides Shasun said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 21, 2015 Category: Pharmaceuticals Source Type: news
Teva Announces Exclusive Launch of Generic Avodart(R) Capsules in the United States
JERUSALEM--(Healthcare Sales & Marketing Network)--Teva Pharmaceutical Industries Ltd., (TEVA) today announced the exclusive launch of the generic equivalent to Avodart® (dutasteride) capsules, 0.5 mg, in the United States. Dutasteride is a 5 alpha-red... Biopharmaceuticals, Urology, Generics, Product LaunchTeva Pharmaceutical, Avodart, dutasteride, benign prostatic hyperplasia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 12, 2015 Category: Pharmaceuticals Source Type: news
Adverse effects of common prostate enlargement and hair growth drugs
Twenty-five percent of men currently taking Finasteride or Dutasteride, popularly known as Proscar and Avodart, for the treatment of benign prostate enlargement, appear not to benefit from taking these medications. Those prescribed Propecia or Avodart for male pattern hair loss (known as alopecia) are also at risk for adverse events elicited by these drugs. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 25, 2015 Category: Science Source Type: news
Adverse effects of common prostate enlargement and hair growth drugs: A review
(Boston University Medical Center) Twenty-five percent of men currently taking Finasteride or Dutasteride, popularly known as Proscar and Avodart, for the treatment of benign prostate enlargement, appear not to benefit from taking these medications. Those prescribed Propecia or Avodart for male pattern hair loss (known as alopecia) are also at risk for adverse events elicited by these drugs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 25, 2015 Category: Global & Universal Source Type: news
Avodart & Proscar for Treating Prostate...
Avodart and Proscar are FDA-approved for treating urinary side effects from prostate enlargement. Does it have anti-cancer effects and is it safe? (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - April 20, 2015 Category: Cancer & Oncology Tags: health Source Type: news
dutasteride (Avodart)
Title: dutasteride (Avodart)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 12/22/2014 12:00:00 AM (Source: MedicineNet Mens Health General)
Source: MedicineNet Mens Health General - December 22, 2014 Category: Primary Care Source Type: news
Dutasteride Plus Tamsulosin vs Tamsulosin Alone for BPHDutasteride Plus Tamsulosin vs Tamsulosin Alone for BPH
This study assesses the economic value of tamsulosin alone or combined with dutasteride for the treatment of BPH. Which is more cost-effective? BMC Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 27, 2014 Category: Consumer Health News Tags: Urology Journal Article Source Type: news
Global and Chinese Dutasteride Industry (CAS 164656-23-9) 2019...
ReportsnReports.com adds Latest Report on “Market Research Report on Global and Chinese Dutasteride(CAS 164656-23-9) Industry, 2009-2019” to its store. Complete report is available at...(PRWeb July 27, 2014)Read the full story at http://www.prweb.com/releases/dutasteride-market/2019-global-and-chinese/prweb12047308.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 27, 2014 Category: Pharmaceuticals Source Type: news
Cancer Headlines from Johns Hopkins (with audio)
(MedPage Today) -- This month's topics include long-term follow-up on finasteride and dutasteride, lung cancer and air pollution, molecular reclassification of brain tumors, and a decision on cells from Henrietta Lacks. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 4, 2013 Category: Hematology Source Type: news
Should You Use Avodart to Reduce Risk of...
Should you use Avodart to reduce your risk of prostate cancer? Avodart (otherwise known as dutasteride) has been used extensively in the past to treat men with benign prostatic hyperplasia (BPH). Learn more about it here. (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - June 23, 2013 Category: Cancer & Oncology Tags: health Source Type: news
Dutasteride (Avodart) and Prostate Cancer
Dutasteride and Prostate Cancer - Dutasteride (Avodart) is a drug that has recently been shown to reduce the risk of developing certain types of prostate cancer. But what else do we know about dutasteride (Avodart) and is it a good idea to take it to prevent prostate cancer? (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - June 10, 2013 Category: Cancer & Oncology Tags: health Source Type: news
New Lawsuit on Avodart High-Grade Prostate Cancer: Now, AttorneyOne...
According to court documents, on February 4th, 2013, a woman filed a lawsuit in Jefferson County District Court alleging her husband developed high-grade prostate cancer from Avodart and died. In...(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10427605.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 15, 2013 Category: Pharmaceuticals Source Type: news
REDUCE follow up study of dutasteride for prostate cancer risk reduction
Source: J Urology
Area: News
The original 4 year REDUCE (REduction by DUtasteride of prostate Cancer Events) trial evaluated dutasteride (0.5mg daily) for prostate cancer risk reduction in men at increased risk for prostate cancer (older age, increased PSA levels) found that dutasteride reduced the relative risk of biopsy detectable prostate cancer by 22.8% (95% CI 15.2-29.8) compared with placebo.
In the current REDUCE Follow-Up Study, 2,751 of the original participants were followed up for an additional two years during which time no drugs were provided and all biopsies were performed for cause. The primary ...
Source: NeLM - News - January 30, 2013 Category: Drugs & Pharmacology Source Type: news
Follow-Up To REDUCE Study Shows Low Rate Of Prostate Cancer Diagnosis
Analysis of 2 Years of Additional Data on Dutasteride Treatment Reported in The Journal of Urology® The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor (5ARI) typically used to treat enlarged prostate. REDUCE results showed that dutasteride decreased the risk of biopsy detectable prostate cancer by 22.8 percent compared to a placebo group, but concerns remained about the drug's effectiveness... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 24, 2013 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news
